Back to results
US 5,403,719 AGranted
Method for assessing prognosis of a patient undergoing therapy for cancer
AssigneesJapan Immuno Research Laboratories Co., Ltd., Sekisui Kagaku Kogyo Kabushiki Kaisha
InventorsMasakazu Adachi, Masahiro Nakatani, Seiichirou Honda
Life of this patent
Estimating the term…
Abstract
A method for assessing the prognosis of a patient undergoing therapy for cancer by measuring the granulocyte/lymphocyte ratio of the patient's blood and comparing the ratio to a normal range of 1.6.+-.0.6. The prognosis is considered improved when the G/L value is within the range as compared to when it is greater than the same.
Claims1
A method of assessing prognosis of a patient undergoing therapy for cancer, which comprises:
- a) measuring a granulocyte/lymphocyte ratio (G/L ratio) of said patient;
- and
- b) comparing said measured G/L ratio in said cancer patient with a G/L ratio range of 1.6.+-.0.6, in order to determine whether the G/L ratio of said patient is within said range or greater,
- whereby prognosis of said patient is indicated as being improved when said measured G/L value is within said range as compared to when said measured G/L valve is greater than said range of 1.6.+-.0.6.
1 more element
Dependencies are inferred from the claim text.